Patent · US Active

Compositions and methods for detection and modulation of T cell mediated immune responses against viral vectors utilized for gene therapy

US11559589B2 · kind B2 · utility

0Cited by
0References
6Claims
0Family size

Assignee

Inventors

Key dates

Filing dateSep 20, 2018
Grant dateJan 24, 2023
Priority date—
Expiry dateJun 26, 2040

Classification

  • Technology area (CPC G)Physics
  • CPC primaryG01N2333/57
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Compositions and methods are provided for inhibiting T cell mediated destruction of virally transduced, trangene containing cells.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.